SEC Company Response from AGENUS INC (AGEN) (CIK 0001098972) (AGEN) — Apr 26, 2016
AGENUS INC (AGEN) (CIK 0001098972)
Date: April 26, 2016 · CIK: 0001098972 · Accession: 0001193125-16-555497
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 000-29089
Letter
April 26, 2016
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street N.E.
Washington, D.C.20549
Attention:
Mary Beth Breslin
Alla Berenshteyn
Suzanne Hayes
Re:
Agenus Inc.
Preliminary Proxy Statement on Schedule 14A
Filed April 15, 2016
File No. 000-29089
Ladies and Gentlemen:
Agenus Inc. (the “Company”) is submitting this letter in response to the written comments of the staff (the “Staff”) of the Division of Corporation Finance of the Securities and Exchange Commission (the “Commission”), dated April 25, 2016 (the “Comment Letter”), with regards to the Company’s Preliminary Proxy Statement on Schedule 14A, filed with the Commission on April 15, 2016.
For the convenience of the Staff’s review, we have set forth the comment contained in the Comment Letter in italics followed by the response of the Company.
Proposal 2, page 53
1. We note that you have proposed an amendment to your certificate of incorporation that would increase the number of authorized shares of your common stock. Please revise your disclosure to describe any specific plans, arrangements or understandings to issue any of the shares that will be newly available for issuance following shareholder approval of the increase. If you have no such plans, please revise your disclosure to so state. If such plans exist, please provide the disclosures required per Note A of Schedule 14A.
Response:
In response to the Staff’s comment, we will revise the disclosure on page 53 of the Company’s Definitive Proxy Statement on Schedule 14A to state that the Company has no specific plans, arrangements or understandings to issue any of the shares that will be newly available for issuance following shareholder approval of the increase.
United States Securities and Exchange Commission
April 26, 2016
Page 2
The Company hereby acknowledges that:
•
it is responsible for the adequacy and accuracy of the disclosure in the filing;
•
Staff comments or changes to disclosure in response to Staff comments do not foreclose the Commission from taking any action with respect to the filing; and
•
the Company may not assert Staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
If the Staff has any questions concerning this letter or requires further information, please do not hesitate to contact me at (781) 674-4433 or Zachary R. Blume, Ropes & Gray LLP, at (617) 951-7663.
Sincerely,
/s/ Karen H. Valentine
Show Raw Text
CORRESP 1 filename1.htm CORRESP April 26, 2016 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street N.E. Washington, D.C.20549 Attention: Mary Beth Breslin Alla Berenshteyn Suzanne Hayes Re: Agenus Inc. Preliminary Proxy Statement on Schedule 14A Filed April 15, 2016 File No. 000-29089 Ladies and Gentlemen: Agenus Inc. (the “Company”) is submitting this letter in response to the written comments of the staff (the “Staff”) of the Division of Corporation Finance of the Securities and Exchange Commission (the “Commission”), dated April 25, 2016 (the “Comment Letter”), with regards to the Company’s Preliminary Proxy Statement on Schedule 14A, filed with the Commission on April 15, 2016. For the convenience of the Staff’s review, we have set forth the comment contained in the Comment Letter in italics followed by the response of the Company. Proposal 2, page 53 1. We note that you have proposed an amendment to your certificate of incorporation that would increase the number of authorized shares of your common stock. Please revise your disclosure to describe any specific plans, arrangements or understandings to issue any of the shares that will be newly available for issuance following shareholder approval of the increase. If you have no such plans, please revise your disclosure to so state. If such plans exist, please provide the disclosures required per Note A of Schedule 14A. Response: In response to the Staff’s comment, we will revise the disclosure on page 53 of the Company’s Definitive Proxy Statement on Schedule 14A to state that the Company has no specific plans, arrangements or understandings to issue any of the shares that will be newly available for issuance following shareholder approval of the increase. United States Securities and Exchange Commission April 26, 2016 Page 2 The Company hereby acknowledges that: • it is responsible for the adequacy and accuracy of the disclosure in the filing; • Staff comments or changes to disclosure in response to Staff comments do not foreclose the Commission from taking any action with respect to the filing; and • the Company may not assert Staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. If the Staff has any questions concerning this letter or requires further information, please do not hesitate to contact me at (781) 674-4433 or Zachary R. Blume, Ropes & Gray LLP, at (617) 951-7663. Sincerely, /s/ Karen H. Valentine Karen H. Valentine Chief Legal Officer and General Counsel Agenus Inc. cc: Via E-Mail Garo H. Armen (Agenus Inc.) Paul Kinsella (Ropes & Gray LLP)